September 13, 11:30 AM
U.S. stocks traded lower, with the Dow Jones tumbling more than 800 points on Tuesday. Here are some big stocks recording gains in today’s session.
August 25, 9:43 AM
JonesTrading analyst Sean Kim initiates coverage on Concert Pharma (NASDAQ:CNCE) with a Buy rating and announces Price Target of $17.
August 1, 6:41 PM
The U.S. Food and Drug Administration (FDA) has cleared the Eledon Pharmaceuticals’ (NASDAQ:ELDN) Investigational New Drug (IND) application…
June 2, 5:20 AM
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock at a public offering price of $4.75 per share.